21.05.12
user : incognito


main page   [site map] [login] [preferences]

topic  

Program of conference 2010

materials comments subscription print view

7th Russian Conference with International participation“Haematopoiesis Immunology” - June 7-9, 2010.

 

«IMMUNOLOGICAL STATEMENT OF THERAPY EFFICACY IN HEMATOLOGIC NEOPLASMS”

PROGRAM

HONORARY CHAIRMAN: Professor George Janossy (London)

June 7,  2010 – arrival of participants, registration

June 8, 2010: 8.30-9.30 registration     

9:30-10.30 Opening ceremony Chairpersons: Prof. Z.G.Kadagidze, Corresponding member of Russian Academy of Medical Sciences Prof. I.V.Poddubnaya, Prof. D.S.Osmanov, Prof. N.N.Tupitsyn
  • Introductory words from Director of N.N. Blokhin Russian Cancer Research Center academician, Professor M.I.Davydov
  • Corresponding member of Russian Academy of Medical Sciences Professor I.V.Poddubnaya Molecular immunological assessment of  therapy efficiency - principal task of oncohaematology
  • Head of Centralized Clinical Laboratory department Professor Z.G.Kadagidze
  • Head of department of chemotherapy of Haemoblastoses Professor D.Sh. Osmanov 
  • Head of Haematopoiesis Immunology Lab. Professor N.N.Tupitsyn
  • Professor G. Janossy (London, UK) “How basic science can lead to simple routine tests for easy interpretation.”     

       10:30-14.00 Morning/Afternoon session «Mature B-cell lymphomas (CD20+), B-CLL and Multiple Myeloma»      

                           Chairpersons:  G. Janossy (London, UK), M. Borowitz (USA), A.Rawstron (UK)

  •  A.V.Shibinskaya (Moscow) "Morphological heterogeneity of B-CLL" - 5 -7 min       

  • Consultant Clinical Scientist, HMDS Department of Haematology St. James's Institute of Oncology (Leeds, UK) À.Rawstron “Minimal residual disease in CLL: clinical implications and standardised approaches with multiparameter flow cytometry
  • A.M.Kovrigina, MD, PhD, DSc, Leading Researcher Dept. Pathological Anatomy of Human Tumors (Cancer Research Center, Moscow) «Aberrant immunophenotypes in mature B-cell Lymphomas” - 15 min           

Coffee-break

·        Consultant Clinical Scientist, HMDS Department of Haematology St. James's Institute of Oncology (Leeds, UK) À.Rawstron “Improvements in the diagnosis and monitoring in B-cell malignancies using flow cytometry

·        Head of Clinical Immunology and Molecular Diagnostics Lab., Cancer Research CenterCenter of Laboratory Diagnostics, St. Petersburg State Medical University named after academician I.P.Pavlov Professor E.E.Zueva, MD, PhD “Multiple Myeloma. Immune diagnosis and statement of treatment efficiency”

·        K.N.Melkova, MD, PhD, Head of Bone Marrow Transplantation Dept.  (Cancer Research Center, Moscow) “Immunological aspects of bone marrow transplantation in Haematologic malignancies”

·        Consultant Clinical Scientist, HMDS Department of Haematology St. James's Institute of Oncology (Leeds, UK) À.Rawstron “Monoclonal B-cell Lymphocytosis: insights into the pathogenesis of CLL”

Discussion

14.00-15.00 Lunch 

15.00-18.00 Evening session “Immunological assessment of acute Leukemia treatment efficiency”Chairpersons: Professor N.N. Tupitsyn, Professor E.E.Zueva, Professor A.V.Popa

  • Professor of Pathology and Oncology Johns Hopkins Medical Institutions (Baltimore, USA) M. Borowitz “Clinical Significance of Minimal Residual Disease Detection in Paediatric ALL”- 45 min
  •  Head of Department of Chemotherapy of Children Hematological Malignancies A.V.Popa (Institute of Children Oncology and Hematology, Cancer Research Center, Moscow) «Minimal residual disease in acute myeloid and lymphoid leukaemias” - 30 min
  • A.M.Popov (Regional Childhood Hospital ¹1, Ekaterinburg, Russia) "Flow cytometric monitoring of minimal residual disease during treatment protocols ALL-MB and MLL-Baby" - 30 min
  • T.Yu.Verzbitskaya, Ph.D. (Regional Childhood Hospital ¹1, Ekaterinburg, Russia) "Detection and monitoring of CNS involvement in children with acute leukaemia by flow cytometry" - 10 min

Coffee-break             

  • Michael R.Loken (Hematologics, Inc, Seattle, ÑØÀ) «Risk stratification in Pediatric AML: combining Karyotype, Molecular and Flow Cytometry Residual Disease Results" 
  • Professor G.Janossy  (London, UK) "Pan-Leucocyte antigen CD45 in routine immunohaematology diagnostics"                       

DISCUSSION              

Closing the Conference